TANNISHA SIMMONS: Open Payments
NPI 1750951414 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 30 payments from 14 companies in 2025. Trend: 2023 $205 · 2024 $284 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $139 |
| ABBVIE INC. | 3 | $102 |
| GlaxoSmithKline, LLC. | 4 | $63 |
| Astellas Pharma US Inc | 2 | $51 |
| PFIZER INC. | 2 | $46 |
| Lilly USA, LLC | 2 | $35 |
| Boston Scientific Corporation | 1 | $34 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Medtronic, Inc. | 1 | $28 |
Products named: QULIPTA, Ozempic, Veozah, SHINGRIX, General - Pain Management, GEMTESA, Rybelsus, NURTEC ODT.
Industry payments across GA — which companies pay providers there.
